{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:23:07Z","timestamp":1789521787154,"version":"build-2803163510"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","award":["18JCZDJC45200"],"award-info":[{"award-number":["18JCZDJC45200"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Science and Technology Program","doi-asserted-by":"publisher","award":["19PTZWHZ00090"],"award-info":[{"award-number":["19PTZWHZ00090"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.intimp.2020.107308","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T13:12:11Z","timestamp":1609161131000},"page":"107308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-7160","authenticated-orcid":false,"given":"Tianming","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangmao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2020.107308_b0005","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/728137","article-title":"A survey of therapeutic effects of artemisia capillaris in liver diseases","volume":"2015","author":"Jang","year":"2015","journal-title":"Evid. Based Complement Alternat. Med."},{"key":"10.1016\/j.intimp.2020.107308_b0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.apsb.2016.06.003","article-title":"The modification of natural products for medical use","volume":"7","author":"Guo","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2020.107308_b0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/157340609787049316","article-title":"Bicyclol: a novel drug for treating chronic viral hepatitis B and C","volume":"5","author":"Liu","year":"2009","journal-title":"Med. Chem."},{"key":"10.1016\/j.intimp.2020.107308_b0020","first-page":"2096","article-title":"Protective effects of bicyclol on liver fibrosis induced by carbon tetrachloride","volume":"84","author":"Li","year":"2004","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.intimp.2020.107308_b0025","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.lfs.2006.02.025","article-title":"Effects of bicyclol on dimethylnitrosamine-induced liver fibrosis in mice and its mechanism of action","volume":"79","author":"Hu","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2020.107308_b0030","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1478-3231.2005.01103.x","article-title":"Mechanism of protective action of bicyclol against CCl-induced liver injury in mice","volume":"25","author":"Liu","year":"2005","journal-title":"Liver Int."},{"key":"10.1016\/j.intimp.2020.107308_b0035","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejphar.2005.12.080","article-title":"Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice","volume":"534","author":"Wang","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2020.107308_b0040","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12192-008-0034-4","article-title":"Bicyclol: a novel antihepatitis drug with hepatic heat shock protein 27\/70-inducing activity and cytoprotective effects in mice","volume":"13","author":"Bao","year":"2008","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.intimp.2020.107308_b0045","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.pupt.2010.12.005","article-title":"Protective effect of bicyclol on lipopolysaccharide-induced acute lung injury in mice","volume":"24","author":"Luo","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2020.107308_b0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1631\/jzus.B1200263","article-title":"Reducing the oxidative stress mediates the cardioprotection of bicyclol against ischemia-reperfusion injury in rats","volume":"14","author":"Cui","year":"2013","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.intimp.2020.107308_b0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brainresbull.2013.11.001","article-title":"Bicyclol upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia","volume":"100","author":"Zhang","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.intimp.2020.107308_b0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.brainres.2013.06.032","article-title":"Neuroprotective effect of bicyclol in rat ischemic stroke: down-regulates TLR4, TLR9, TRAF6, NF-kappaB, MMP-9 and up-regulates claudin-5 expression","volume":"1528","author":"Zhang","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2020.107308_b0065","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.biopha.2017.05.041","article-title":"Bicyclol exerts an anti-tumor effect via ROS-mediated endoplasmic reticulum stress in human renal cell carcinoma cells","volume":"91","author":"Wu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2020.107308_b0070","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/jcb.29310","article-title":"Protective effect of bicyclol against pulmonary fibrosis via regulation of microRNA-455-3p in rats","volume":"121","author":"Zhou","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.intimp.2020.107308_b0075","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2020.107308_b0080","doi-asserted-by":"crossref","unstructured":"G.B.D. Mortality, Causes of Death C. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet 385 (2015) 117\u2013171.","DOI":"10.1016\/S0140-6736(14)61682-2"},{"key":"10.1016\/j.intimp.2020.107308_b0085","unstructured":"C. Global Burden of Disease Study, Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet 386 (2015) 743\u2013800."},{"key":"10.1016\/j.intimp.2020.107308_b0090","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.intimp.2020.107308_b0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jvh.12444","article-title":"Hepatitis B: 50 years after the discovery of Australia antigen","volume":"23","author":"Lok","year":"2016","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.intimp.2020.107308_b0100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.5694\/mja11.11531","article-title":"The changing therapeutic landscape for hepatitis C","volume":"196","author":"Dore","year":"2012","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.intimp.2020.107308_b0105","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0140-6736(10)61497-3","article-title":"Curing hepatitis C with pills: a step toward global control","volume":"376","author":"Thomas","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2020.107308_b0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12985-018-0945-3","article-title":"Plant-derived antivirals against hepatitis c virus infection","volume":"15","author":"Jardim","year":"2018","journal-title":"Virol. J."},{"key":"10.1016\/j.intimp.2020.107308_b0115","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.3748\/wjg.15.3472","article-title":"Targeting host factors: a novel rationale for the management of hepatitis C virus","volume":"15","author":"Khattab","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2020.107308_b0120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/hep4.1050","article-title":"Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: a systematic review","volume":"1","author":"Bartlett","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.intimp.2020.107308_b0125","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.3390\/v7112898","article-title":"Host-targeting agents to prevent and cure hepatitis C virus infection","volume":"7","author":"Zeisel","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2020.107308_b0130","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.apsb.2019.01.013","article-title":"Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication","volume":"9","author":"Huang","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2020.107308_b0135","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrgastro.2015.53","article-title":"Treatment of hepatitis C in difficult-to-treat patients","volume":"12","author":"Ferenci","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2020.107308_b0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jhep.2018.10.023","article-title":"Inflammatory pathways in alcoholic steatohepatitis","volume":"70","author":"Gao","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2020.107308_b0145","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12072-018-9911-9","article-title":"DAMPs and sterile inflammation in drug hepatotoxicity","volume":"13","author":"Yang","year":"2019","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.intimp.2020.107308_b0150","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0940-2993(96)80058-3","article-title":"Immunotoxicology of T cell-dependent experimental liver injury","volume":"48","author":"Tiegs","year":"1996","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.intimp.2020.107308_b0155","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.3748\/wjg.v10.i12.1775","article-title":"Inhibition of Fas\/FasL mRNA expression and TNF-alpha release in concanavalin A-induced liver injury in mice by bicyclol","volume":"10","author":"Li","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2020.107308_b0160","first-page":"206","article-title":"Bicyclol attenuates pro-inflammatory cytokine and chemokine productions in CpG-DNA-stimulated L02 hepatocytes by inhibiting p65-NF-kappaB and p38-MAPK activation","volume":"65","author":"Lou","year":"2010","journal-title":"Pharmazie"},{"key":"10.1016\/j.intimp.2020.107308_b0165","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","article-title":"Quantitative expression of toll-like receptor 1\u201310 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides","volume":"168","author":"Hornung","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2020.107308_b0170","first-page":"144","article-title":"Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C","volume":"36","author":"Falasca","year":"2006","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.intimp.2020.107308_b0175","article-title":"Protective effect of bicyclol on anti-tuberculosis drug induced liver injury in rats","volume":"22","author":"Liu","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2020.107308_b0180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fphar.2020.00463","article-title":"Bicyclol attenuates acute liver injury by activating autophagy, anti-oxidative and anti-inflammatory capabilities in mice","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2020.107308_b0185","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(19)31894-X","article-title":"Acute liver failure","volume":"394","author":"Stravitz","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2020.107308_b0190","doi-asserted-by":"crossref","first-page":"3946706","DOI":"10.1155\/2017\/3946706","article-title":"The protective effect of cordycepin on D-galactosamine\/lipopolysaccharide-induced acute liver injury","volume":"2017","author":"Li","year":"2017","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.intimp.2020.107308_b0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.intimp.2014.07.008","article-title":"Role of alpha-lipoic acid in LPS\/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis","volume":"22","author":"Xia","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2020.107308_b0200","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ptr.1632","article-title":"Hepatoprotective activity of aqueous-methanol extract of Artemisia vulgaris","volume":"19","author":"Gilani","year":"2005","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2020.107308_b0205","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/2225-4110.114898","article-title":"Therapeutic potential of traditional chinese medicine on inflammatory diseases","volume":"3","author":"Tsai","year":"2013","journal-title":"J. Tradit. Complement. Med."},{"key":"10.1016\/j.intimp.2020.107308_b0210","doi-asserted-by":"crossref","first-page":"F840","DOI":"10.1152\/ajprenal.00187.2002","article-title":"Substance P via NK1 receptor facilitates hyperactive bladder afferent signaling via action of ROS","volume":"284","author":"Chien","year":"2003","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.intimp.2020.107308_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047299","article-title":"Activating Nrf-2 signaling depresses unilateral ureteral obstruction-evoked mitochondrial stress-related autophagy, apoptosis and pyroptosis in kidney","volume":"7","author":"Chung","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2020.107308_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2020.107308_b0225","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2174\/0929867326666190517113533","article-title":"The effects of dietary supplements that overactivate the Nrf2\/ARE system","volume":"27","author":"Smith","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2020.107308_b0230","first-page":"942","article-title":"Effects of bicyclol on aflatoxin B1 metabolism and hepatotoxicity in rats","volume":"23","author":"Lu","year":"2002","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2020.107308_b0235","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejphar.2008.02.059","article-title":"Protective effect of bicyclol on acute alcohol-induced liver injury in mice","volume":"586","author":"Zhao","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2020.107308_b0240","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1191\/0748233705th216oa","article-title":"The activities of liver adenosine deaminase, xanthine oxidase, catalase, superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: protective effect of caffeic acid phenethyl ester","volume":"21","author":"Yilmaz","year":"2005","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.intimp.2020.107308_b0245","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00144618","article-title":"Evidence for the involvement of nitric oxide in cisplatin-induced toxicity in rats","volume":"9","author":"Srivastava","year":"1996","journal-title":"Biometals"},{"key":"10.1016\/j.intimp.2020.107308_b0250","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1742-7843.2008.00343.x","article-title":"Effect of bicyclol on cisplatin-induced hepatotoxicity in the hepatocarcinoma 22 tumour-bearing mice","volume":"104","author":"Yu","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.intimp.2020.107308_b0255","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s10620-009-0715-6","article-title":"Effects of bicyclol on liver regeneration after partial hepatectomy in rats","volume":"54","author":"Yao","year":"2009","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.intimp.2020.107308_b0260","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2020.107308_b0265","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"150","author":"Machado","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2020.107308_b0270","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tox.2009.04.058","article-title":"Protective effect of bicyclol on tetracycline-induced fatty liver in mice","volume":"261","author":"Yu","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.intimp.2020.107308_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/cjpp-2015-0074","article-title":"Bicyclol attenuates tetracycline-induced fatty liver associated with inhibition of hepatic ER stress and apoptosis in mice","volume":"94","author":"Yao","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.intimp.2020.107308_b0280","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1211\/jpp.59.12.0007","article-title":"Bicyclol, a synthetic dibenzocyclooctadiene derivative, decreases hepatic lipids but increases serum triglyceride level in normal and hypercholesterolaemic mice","volume":"59","author":"Pan","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.intimp.2020.107308_b0285","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2015.03.039","article-title":"Mechanisms of liver fibrosis resolution","volume":"63","author":"Tacke","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2020.107308_b0290","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.taap.2014.08.006","article-title":"TGF-beta1-elevated TRPM7 channel regulates collagen expression in hepatic stellate cells via TGF-beta1\/Smad pathway","volume":"280","author":"Fang","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2020.107308_b0295","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.intimp.2020.107308_b0300","article-title":"Liver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cells","volume":"2014","author":"Duval","year":"2014","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2020.107308_b0305","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/10286021003789047","article-title":"Effects of bicyclol on immunological liver fibrosis in rats","volume":"12","author":"Gu","year":"2010","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.intimp.2020.107308_b0310","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.3748\/wjg.v21.i23.7155","article-title":"Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats","volume":"21","author":"Zhen","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2020.107308_b0315","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4254\/wjh.v9.i21.907","article-title":"Chemotherapy for hepatocellular carcinoma: the present and the future","volume":"9","author":"Le Grazie","year":"2017","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.intimp.2020.107308_b0320","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/JHC.S107370","article-title":"Hepatocellular carcinoma: early-stage management challenges","volume":"4","author":"Erstad","year":"2017","journal-title":"J. Hepatocell Carcinoma"},{"key":"10.1016\/j.intimp.2020.107308_b0325","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.canlet.2005.05.019","article-title":"Chemopreventive effect of bicyclol on malignant transformation of WB-F344 rat liver epithelial cells and its effect on related signal transduction in vitro","volume":"236","author":"Sun","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2020.107308_b0330","first-page":"595","article-title":"Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis","volume":"88","author":"Solt","year":"1977","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2020.107308_b0335","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.4161\/cbt.5.12.3377","article-title":"Chemoprevention of bicyclol against hepatic preneoplastic lesions","volume":"5","author":"Zhu","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.intimp.2020.107308_b0340","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/584728","article-title":"A novel antihepatitis drug, bicyclol, prevents liver carcinogenesis in diethylnitrosamine-initiated and phenobarbital-promoted mice tumor model","volume":"2012","author":"Sun","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.intimp.2020.107308_b0345","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1186\/s12885-016-2767-2","article-title":"Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K\/AKT and Ras\/Raf\/MEK\/ERK pathways","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.intimp.2020.107308_b0350","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/10286020902942368","article-title":"Inhibitory effect of anti-hepatitis drug bicyclol on invasion of human hepatocellular carcinoma MHCC97-H cells with high metastasis potential and its relative mechanisms","volume":"11","author":"Sun","year":"2009","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.intimp.2020.107308_b0355","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4161\/cbt.5.5.2655","article-title":"Chemosensitizing multiple drug resistance of human carcinoma by Bicyclol involves attenuated p-glycoprotein, GST-P and Bcl-2","volume":"5","author":"Zhu","year":"2006","journal-title":"Cancer Biol. Ther."},{"issue":"765\u2013783","key":"10.1016\/j.intimp.2020.107308_b0360","article-title":"Cell death and cell death responses in liver disease: mechanisms and clinical relevance","volume":"147","author":"Luedde","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2020.107308_b0365","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1053\/gast.2002.36061","article-title":"AGA technical review on the evaluation of liver chemistry tests","volume":"123","author":"Green","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2020.107308_b0370","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2020.107308_b0375","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5009\/gnl18486","article-title":"Cell death and liver disease","volume":"14","author":"Aizawa","year":"2020","journal-title":"Gut Liver"},{"key":"10.1016\/j.intimp.2020.107308_b0380","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.intimp.2020.107308_b0385","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nri.2015.7","article-title":"Converging roles of caspases in inflammasome activation, cell death and innate immunity","volume":"16","author":"Man","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2020.107308_b0390","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","article-title":"Apoptosis and necroptosis in the liver: a matter of life and death","volume":"15","author":"Schwabe","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2020.107308_b0395","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/aps.2009.194","article-title":"Bicyclol protects HepG2 cells against D-galactosamine-induced apoptosis through inducing heat shock protein 27 and mitochondria associated pathway","volume":"31","author":"Bao","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2020.107308_b0400","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2020.107308_b0405","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/35056522","article-title":"Molecular dissection of autophagy: two ubiquitin-like systems","volume":"2","author":"Ohsumi","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2020.107308_b0410","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri2161","article-title":"Unveiling the roles of autophagy in innate and adaptive immunity","volume":"7","author":"Levine","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2020.107308_b0415","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrgastro.2016.185","article-title":"Autophagy in the liver: functions in health and disease","volume":"14","author":"Ueno","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2020.107308_b0420","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010060","article-title":"Heat shock proteins: agents of cancer development and therapeutic targets in anti-cancer therapy","volume":"9","author":"Yun","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2020.107308_b0425","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tips.2016.11.009","article-title":"Heat shock proteins and cancer","volume":"38","author":"Wu","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2020.107308_b0430","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1124\/mol.108.053280","article-title":"Induction of overexpression of the 27- and 70-kDa heat shock proteins by bicyclol attenuates concanavalin A-Induced liver injury through suppression of nuclear factor-kappaB in mice","volume":"75","author":"Bao","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.intimp.2020.107308_b0435","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/10286021003769924","article-title":"Involvement of HSP70 in the protection of bicyclol on apoptosis of HepG2 cells intoxicated by d-galactosamine","volume":"12","author":"Bao","year":"2010","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.intimp.2020.107308_b0440","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ejphar.2016.09.002","article-title":"Induction of heat shock protein 27 by bicyclol attenuates d-galactosamine\/lipopolysaccharide-induced liver injury","volume":"791","author":"Dai","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2020.107308_b0445","article-title":"Scoparone as a therapeutic drug in liver diseases: Pharmacology, pharmacokinetics and molecular mechanisms of action","volume":"105170","author":"Hui","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2020.107308_b0450","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jchromb.2008.02.016","article-title":"Simultaneous quantification of four active schisandra lignans from a traditional Chinese medicine Schisandra chinensis(Wuweizi) in rat plasma using liquid chromatography\/mass spectrometry","volume":"865","author":"Wang","year":"2008","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.intimp.2020.107308_b0455","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.jchromb.2010.06.014","article-title":"Determination of bicyclol in dog plasma using liquid chromatography-tandem mass spectrometry","volume":"878","author":"Sheng","year":"2010","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.intimp.2020.107308_b0460","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4654","article-title":"Pharmacokinetic analysis of plasma bicyclol by liquid chromatography-tandem mass spectrometry","volume":"33","author":"Liu","year":"2019","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.intimp.2020.107308_b0465","first-page":"656","article-title":"Effects of bicyclol on the activity and expression of CYP450 enzymes of rats after partial hepatectomy","volume":"46","author":"Yao","year":"2011","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.intimp.2020.107308_b0470","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3109\/03639045.2011.650643","article-title":"Preparation and evaluation of bicyclol microemulsions for enhanced oral bioavailability","volume":"38","author":"Ryu","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.intimp.2020.107308_b0475","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/00498254.2018.1524186","article-title":"Evaluation of pharmacokinetic interactions between bicyclol and co-administered drugs in rat and human liver microsomes in vitro and in rats in vivo","volume":"49","author":"Yang","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1016\/j.intimp.2020.107308_b0480","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3748\/wjg.v11.i5.665","article-title":"Toxicity of novel anti-hepatitis drug bicyclol: a preclinical study","volume":"11","author":"Liu","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2020.107308_b0485","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s11655-018-2553-x","article-title":"Genotoxicity and embryotoxicity study of bicyclol methyl ether, main impurity in bicyclol","volume":"25","author":"Zhang","year":"2019","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.intimp.2020.107308_b0490","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12072-011-9294-7","article-title":"A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol","volume":"6","author":"Xie","year":"2012","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.intimp.2020.107308_b0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40261-013-0136-3","article-title":"Randomized, vitamin E-controlled trial of bicyclol plus metformin in non-alcoholic fatty liver disease patients with impaired fasting glucose","volume":"34","author":"Han","year":"2014","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.intimp.2020.107308_b0500","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1177\/0300060514527058","article-title":"Role of bicyclol in preventing chemotherapeutic agent-induced liver injury in patients over 60 years of age with cancer","volume":"42","author":"Li","year":"2014","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.intimp.2020.107308_b0505","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5588\/ijtld.14.0579","article-title":"Role of bicyclol in preventing drug-induced liver injury in tuberculosis patients with liver disease","volume":"19","author":"Chu","year":"2015","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.intimp.2020.107308_b0510","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.12659\/MSM.904090","article-title":"A multicenter and randomized controlled trial of bicyclol in the treatment of statin-induced liver injury","volume":"23","author":"Naiqiong","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.intimp.2020.107308_b0515","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1515\/med-2017-0012","article-title":"Effect of bicyclol tablets on drug induced liver injuries after kidney transplantation","volume":"12","author":"Shang","year":"2017","journal-title":"Open Med. (Wars)"},{"key":"10.1016\/j.intimp.2020.107308_b0520","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12876-019-1005-1","article-title":"Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience","volume":"19","author":"Chi","year":"2019","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.intimp.2020.107308_b0525","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1515\/med-2018-0010","article-title":"Pharmacoeconomics of three therapeutic schemes for anti-tuberculosis therapy induced liver injury in China","volume":"13","author":"Chen","year":"2018","journal-title":"Open Med. (Wars)"},{"key":"10.1016\/j.intimp.2020.107308_b0530","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41419-020-2732-5","article-title":"The emerging role of ferroptosis in non-cancer liver diseases: hype or increasing hope?","volume":"11","author":"Mao","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2020.107308_b0535","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.chembiol.2020.03.011","article-title":"Breakdown of an ironclad defense system: the critical role of NRF2 in mediating ferroptosis","volume":"27","author":"Anandhan","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.intimp.2020.107308_b0540","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41419-020-02961-5","article-title":"(+)-Clausenamide protects against drug-induced liver injury by inhibiting hepatocyte ferroptosis","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2020.107308_b0545","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1200\/JOP.18.00005","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of clinical oncology clinical practice guideline summary","volume":"14","author":"Brahmer","year":"2018","journal-title":"J. Oncol. Pract."},{"key":"10.1016\/j.intimp.2020.107308_b0550","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/17425255.2019.1574744","article-title":"Hepatotoxicity induced by immune checkpoint inhibitors: a comprehensive review including current and alternative management strategies","volume":"15","author":"Jennings","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.intimp.2020.107308_b0555","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40425-017-0300-z","article-title":"Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group","volume":"5","author":"Puzanov","year":"2017","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.intimp.2020.107308_b0560","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/1759-7714.13463","article-title":"Compromise or not? A case report of successful treatment of pembrolizumab-induced hepatitis in a patient with non-small cell lung cancer with low-dose methylprednisolone and bicyclol","volume":"11","author":"Liu","year":"2020","journal-title":"Thorac. Cancer"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920337759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920337759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:21:50Z","timestamp":1761585710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920337759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":112,"alternative-id":["S1567576920337759"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107308","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107308"}}